I've been busy and haven't fully caught up.
No one said this was a well executed CR, so you are not the lone ranger there!
I don't know why $97m was the magic number that Mesoblast wanted, but neither do you.
The fact is $60m was raised and that is enough as a bridge for Mesoblast to get to more tangible news.
Who knows what's installed in Q1 2024 - maybe monetisation of royalties or partnership $$$.
Back to the Shortfall provision - there are a few clauses there.
"Price per share no less than the Issue Price" - so if we get good news, they can ask for this to be higher than 30c - right?
"MSB's register and any potential control impacts" - this is at the discretion of MSB directors. So why would they disadvantage Mesoblast if good news were available?
Ann: Update on Institutional Placement and Entitlement Offer, page-62
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $7.014M | 4.343M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 342 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 54534 | 8 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |